Abbreviated Company Accounts - BIOEMULOUS LIMITED

Abbreviated Company Accounts - BIOEMULOUS LIMITED


Registered Number 08905301

BIOEMULOUS LIMITED

Abbreviated Accounts

30 November 2015

BIOEMULOUS LIMITED Registered Number 08905301

Abbreviated Balance Sheet as at 30 November 2015

Notes 2015 2014
£ £
Current assets
Debtors 13,499 13,499
Cash at bank and in hand 9 501
13,508 14,000
Creditors: amounts falling due within one year (1,330) (720)
Net current assets (liabilities) 12,178 13,280
Total assets less current liabilities 12,178 13,280
Total net assets (liabilities) 12,178 13,280
Capital and reserves
Called up share capital 2 14,792 13,750
Share premium account 148,707 24,750
Profit and loss account (151,321) (25,220)
Shareholders' funds 12,178 13,280
  • For the year ending 30 November 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 24 August 2016

And signed on their behalf by:
Alan Charles Bashforth, Director

BIOEMULOUS LIMITED Registered Number 08905301

Notes to the Abbreviated Accounts for the period ended 30 November 2015

1Accounting Policies

Basis of measurement and preparation of accounts
The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).

2Called Up Share Capital
Allotted, called up and fully paid:
2015
£
2014
£
1,479,166 Ordinary shares of £0.01 each (1,375,000 shares for 2014) 14,792 13,750

During the period the Company allotted 104,166 Ordinary £0.01 shares. The total consideration in respect of these shares was £125,000.